Skip to main content
Premium Trial:

Request an Annual Quote

Ingenium Pharmaceuticals and Tuebingen Link up on Eye Research

NEW YORK, April 16 - Ingenium Pharmaceuticals and the molecular genetics laboratory of the University Eye Hospital of Tuebingen, Germany, today announced a research collaboration to create animal models with defined gene alterations for research into the genes related to eye diseases.


Financial details were not disclosed.


The project will use Ingenium's genotyping platform to create mammalian models that carry alterations in target genes. The university researchers will use the models to characterize gene functions and screen for drugs for treatment of ocular neuropathies, such as glaucoma.